• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

    63.88 -0.31 (-0.48%)
    Streaming Delayed Price Updated: 9:53 AM EST, Dec 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 49,711
    Open 64.14
    Bid (Size) 63.78 (100)
    Ask (Size) 63.97 (100)
    Prev. Close 64.18
    Today's Range 63.28 - 64.15
    52wk Range 29.31 - 70.98
    Shares Outstanding 95,640,600
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Holley Inc. (NYSE: HLLY); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious? ↗
    The FDA approved 5 mg, 10 mg, 15 mg, 20 mg Myqorzo tablets for the treatment of symptomatic obstructive hypertrophic cardiomyopathy. 
    Via Stocktwits

    Performance

    YTD
    +30.5%
    +30.5%
    1 Month
    -5.4%
    -5.4%
    3 Month
    +33.5%
    +33.5%
    6 Month
    +88.4%
    +88.4%
    1 Year
    +31.6%
    +31.6%

    More News

    Read More
    News headline image
    This Cytokinetics Director Sold 5,000 Shares in November. Is It Time to Dump the Biopharmaceutical Stock? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Holley Inc. (NYSE: HLLY); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Notice For Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Inspire Medical Systems, Inc. (NYSE: INSP); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and Stride, Inc. (NYSE: LRN): Grabar Law Office is Investigating Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and Stride, Inc. (NYSE: LRN): Grabar Law Office is Investigating Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    What Does the Market Think About Cytokinetics Inc? ↗
    Via Benzinga
    News headline image
    Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); enCore Energy Corp. (NASDAQ: EU); Fluor Corporation (NYSE: FLR); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Urgently Reminds Investors of Cytokinetics, Quanex, Freeport, and Primo Brands to Contact the Firm About their Rights
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    CYTK FINAL DEADLINE: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
    Via TheNewswire.com
    Topics Earnings Fraud Lawsuit
    News headline image
    Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
    Via NewMediaWire
    Topics Earnings Fraud Lawsuit
    News headline image
    Cytokinetics 72 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
    From Kahn Swick & Foti, LLC
    Via Business Wire

    Frequently Asked Questions

    Is Cytokinetics, Incorporated - Common Stock publicly traded?
    Yes, Cytokinetics, Incorporated - Common Stock is publicly traded.
    What exchange does Cytokinetics, Incorporated - Common Stock trade on?
    Cytokinetics, Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Cytokinetics, Incorporated - Common Stock?
    The ticker symbol for Cytokinetics, Incorporated - Common Stock is CYTK on the Nasdaq Stock Market
    What is the current price of Cytokinetics, Incorporated - Common Stock?
    The current price of Cytokinetics, Incorporated - Common Stock is 63.88
    When was Cytokinetics, Incorporated - Common Stock last traded?
    The last trade of Cytokinetics, Incorporated - Common Stock was at 12/26/25 09:53 AM ET
    What is the market capitalization of Cytokinetics, Incorporated - Common Stock?
    The market capitalization of Cytokinetics, Incorporated - Common Stock is 6.11B
    How many shares of Cytokinetics, Incorporated - Common Stock are outstanding?
    Cytokinetics, Incorporated - Common Stock has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.